Clinical Treatment of Elderly Patients with Chronic Atrial Fibrillation and Heart Failure
Keywords:
Atrial fibrillation, Heart failure, Clinical treatment
Abstract
Objective: To study the clinical treatment of chronic atrial fibrillation and heart failure in elderly patients. Method: In our hospital, 120 patients with chronic atrial fibrillation complicated with heart failure were selected from March 2011 to March 2014 as the study subject. The clinical treatment of chronic atrial fibrillation with heart failure was discussed by comparing with the control group and the treatment group. Results: After 1 months of treatment, the total effective rate was 90% in the treatment group and 70% in the control group, the average recovery time of the treatment group was (4.45 + 0.88) day, and the average recovery time of the control group was (7.76 + 1.34) day. Conclusion: To improve cardiac function and ventricular remodeling, heart rate control, blocking neurosecretory system in the treatment for elderly patients with chronic atrial fibrillation and heart failure patients affect significantly, has very important clinical value.References
1. Zhang L. Treatment strategy for elderly patients with chronic atrial fibrillation combined with heart failure. Chinese Journal of Clinical Medicine. 2013;24:819‒822.
2. Wang L, Ma J, Chen K. 1410 patients with chronic heart failure complicated by atrial fibrillation. 2007;12(1):5‒8.
3. Zhang H. Steady heart pellet jointly doubles his Leg in the treatment of chronic heart failure complicated with atrial fibrillation in 43 cases of the observation. Zhejiang Journal of Traditional Chinese Medicine. 2012;47(10):719.
2. Wang L, Ma J, Chen K. 1410 patients with chronic heart failure complicated by atrial fibrillation. 2007;12(1):5‒8.
3. Zhang H. Steady heart pellet jointly doubles his Leg in the treatment of chronic heart failure complicated with atrial fibrillation in 43 cases of the observation. Zhejiang Journal of Traditional Chinese Medicine. 2012;47(10):719.
Published
2015-02-27
Issue
Section
Original Research Article
Copyright (c) 2015 Haifeng Liu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.
